MM-310

· Merrimack Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MM-310, covering 2018-02-27 to 2018-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating MM-310 in Patients With Solid Tumors [Phase 1]